Perseus Proteomics (TSE:4882) Institutional Ownership: 0.28% (As of Aug. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4882 Perseus Proteomics Inc TSE:4882
60 GF Score
Price 円142.00
GF Value 円441.00
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Perseus Proteomics Institutional Ownership?

Perseus Proteomics TSE:4882 60 Institutional Ownership is 0.28% as of Aug. 10, 2026. GuruFocus rates TSE:4882 with a GF Score™ of 60/100 and a GF Value™ of 円441.00 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Perseus Proteomics's institutional ownership is 0.28%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Perseus Proteomics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Perseus Proteomics's Float Percentage Of Total Shares Outstanding is 0.00%.

Perseus Proteomics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Perseus Proteomics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perseus Proteomics Institutional Ownership Chart

Perseus Proteomics Historical Data

The historical data trend for Perseus Proteomics can be seen below:

2025-03-31 2025-04-30 2025-05-31 2025-06-30 2025-07-31 2025-08-31 2025-09-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 0.72 0.72 0.70 0.69 0.67 0.66 0.23 0.28 0.28 0.28
TSE:4882
60GF Score
Perseus Proteomics Inc TSE:4882
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perseus Proteomics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.28% mean?
Perseus Proteomics (TSE:4882) has a Institutional Ownership of 0.28% as of Aug. 10, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Perseus Proteomics and its competitors.
Is Perseus Proteomics' Institutional Ownership too high?
Perseus Proteomics' current Institutional Ownership is 0.28%. Overall, Perseus Proteomics has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Perseus Proteomics' Institutional Ownership compare to LLY and JNJ?
Perseus Proteomics' Institutional Ownership of 0.28% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Perseus Proteomics and its competitors. Perseus Proteomics's current Institutional Ownership is 0.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perseus Proteomics stock overvalued right now?
Based on GuruFocus' analysis, Perseus Proteomics (TSE:4882) is currently considered Significantly Undervalued. The stock's GF Value™ is 円441.00, compared to a current price of 円142.00 — trading 67.8% below its estimated fair value. The current Institutional Ownership is 0.28%. Perseus Proteomics' overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Perseus Proteomics (TSE:4882), the current Institutional Ownership is 0.28% as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perseus Proteomics (TSE:4882) Overvalued in 2026?

Based on GuruFocus' analysis, Perseus Proteomics stock appears to be undervalued. The current stock price of 円142.00 is trading 67.8% below its estimated GF Value™ of 円441.00. GuruFocus considers Perseus Proteomics to be Significantly Undervalued.

Key valuation signals for TSE:4882:

  • Institutional Ownership: 0.28%
  • GF Value™: 円441.00 vs. price of 円142.00 (67.8% below fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the TSE:4882 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perseus Proteomics Business Description

Address 30-1 Hakozakicho, Nihonbashi, Chuo-ku, AiNihombashi EAST 3rd floor, Tokyo, JPN, 103-0015
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody-based therapeutics and diagnostic drugs to cure cancer and other diseases. The Company operates in a single segment, the pharmaceutical business.
60GF Score

Get the complete analysis for TSE:4882

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円142.00
Price
円441.00
GF Value